Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
- PMID: 37377417
- PMCID: PMC10470516
- DOI: 10.1128/mbio.00074-23
Caspofungin-induced β(1,3)-glucan exposure in Candida albicans is driven by increased chitin levels
Abstract
To successfully induce disease, Candida albicans must effectively evade the host immune system. One mechanism used by C. albicans to achieve this is to mask immunogenic β(1,3)-glucan epitopes within its cell wall under an outer layer of mannosylated glycoproteins. Consequently, induction of β(1,3)-glucan exposure (unmasking) via genetic or chemical manipulation increases fungal recognition by host immune cells in vitro and attenuates disease during systemic infection in mice. Treatment with the echinocandin caspofungin is one of the most potent drivers of β(1,3)-glucan exposure. Several reports using murine infection models suggest a role for the immune system, and specifically host β(1,3)-glucan receptors, in mediating the efficacy of echinocandin treatment in vivo. However, the mechanism by which caspofungin-induced unmasking occurs is not well understood. In this report, we show that foci of unmasking co-localize with areas of increased chitin within the yeast cell wall in response to caspofungin, and that inhibition of chitin synthesis via nikkomycin Z attenuates caspofungin-induced β(1,3)-glucan exposure. Furthermore, we find that both the calcineurin and Mkc1 mitogen-activated protein kinase pathways work synergistically to regulate β(1,3)-glucan exposure and chitin synthesis in response to drug treatment. When either of these pathways are interrupted, it results in a bimodal population of cells containing either high or low chitin content. Importantly, increased unmasking correlates with increased chitin content within these cells. Microscopy further indicates that caspofungin-induced unmasking correlates with actively growing cells. Collectively, our work presents a model in which chitin synthesis induces unmasking within the cell wall in response to caspofungin in growing cells. IMPORTANCE Systemic candidiasis has reported mortality rates ranging from 20% to 40%. The echinocandins, including caspofungin, are first-line antifungals used to treat systemic candidiasis. However, studies in mice have shown that echinocandin efficacy relies on both its cidal impacts on Candida albicans, as well as a functional immune system to successfully clear invading fungi. In addition to direct C. albicans killing, caspofungin increases exposure (unmasking) of immunogenic β(1,3)-glucan moieties. To evade immune detection, β(1,3)-glucan is normally masked within the C. albicans cell wall. Consequently, unmasked β(1,3)-glucan renders these cells more visible to the host immune system and attenuates disease progression. Therefore, discovery of how caspofungin-induced unmasking occurs is needed to elucidate how the drug facilitates host immune system-mediated clearance in vivo. We report a strong and consistent correlation between chitin deposition and unmasking in response to caspofungin and propose a model in which altered chitin synthesis drives increased unmasking during drug exposure.
Keywords: Candida albicans; caspofungin; chitin; unmasking; β-glucan.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f006.gif)
![Fig 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f007.gif)
![Fig 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f008.gif)
![Fig 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10470516/bin/mbio.00074-23.f009.gif)
Comment in
-
Ex-chitin-g news on drug-induced fungal epitope unmasking.mBio. 2023 Oct 31;14(5):e0138723. doi: 10.1128/mbio.01387-23. Epub 2023 Oct 3. mBio. 2023. PMID: 37787544 Free PMC article.
Similar articles
-
Cek1 regulates ß(1,3)-glucan exposure through calcineurin effectors in Candida albicans.PLoS Genet. 2022 Sep 19;18(9):e1010405. doi: 10.1371/journal.pgen.1010405. eCollection 2022 Sep. PLoS Genet. 2022. PMID: 36121853 Free PMC article.
-
Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.PLoS Pathog. 2008 Dec;4(12):e1000227. doi: 10.1371/journal.ppat.1000227. Epub 2008 Dec 5. PLoS Pathog. 2008. PMID: 19057660 Free PMC article.
-
Elevated chitin content reduces the susceptibility of Candida species to caspofungin.Antimicrob Agents Chemother. 2013 Jan;57(1):146-54. doi: 10.1128/AAC.01486-12. Epub 2012 Oct 22. Antimicrob Agents Chemother. 2013. PMID: 23089748 Free PMC article.
-
Caspofungin resistance in Candida albicans: genetic factors and synergistic compounds for combination therapies.Braz J Microbiol. 2022 Sep;53(3):1101-1113. doi: 10.1007/s42770-022-00739-9. Epub 2022 Mar 29. Braz J Microbiol. 2022. PMID: 35352319 Free PMC article. Review.
-
Natural products targeting the synthesis of β(1,3)-D-glucan and chitin of the fungal cell wall. Existing drugs and recent findings.Phytomedicine. 2021 Jul 15;88:153556. doi: 10.1016/j.phymed.2021.153556. Epub 2021 Mar 27. Phytomedicine. 2021. PMID: 33958276 Review.
Cited by
-
Adaptative survival of Aspergillus fumigatus to echinocandins arises from cell wall remodeling beyond β-1,3-glucan synthesis inhibition.Nat Commun. 2024 Jul 31;15(1):6382. doi: 10.1038/s41467-024-50799-8. Nat Commun. 2024. PMID: 39085213 Free PMC article.
References
-
- Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung S, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. 2010. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681–691. doi:10.1016/j.immuni.2010.05.001 - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources